New research out of the University of North Carolina (UNC) found that Merck's new anti-covid drug molnupiravir causes cancer. The so-called "miracle" drug, which we reported is [.]
While the Food and Drug Administration (FDA) is expected to soon rule on whether to authorize Merck's COVID-19 pill, questions remain regarding its risks in pregnant women.